RETRO (REduction of Therapy in RA Patients in Ongoing Remission)
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This is a phase 3, multicenter, randomized, open, prospective, controlled, parallel-group
intervention study in 318 patients with Rheumatoid Arthritis. The study is composed of 3
phases: a pre-randomization phase for up to 10 days followed by a 1-year randomized, open
three arm treatment phase for each patient, followed by a 5-year observational phase for all
patients still in remission.